BACKGROUND: We developed estimates of community viral load (VL) and risk factors for unsuppressed VL from a cross-sectional study of men who have sex with men (MSM) in Vancouver, Canada. METHODS: MSM were recruited from February 25, 2012 to February 28, 2014 using respondent-driven sampling (RDS). Participants completed a computer-assisted self-interview questionnaire and a nurse-administered point-of-care HIV test. For HIV-positive participants, we conducted VL and CD4 cell counts. We used RDS-weighted analysis to obtain population estimates of key variables and multivariable logistic regression to examine factors associated with having a VL of ≥200 copies per milliliter among HIV-positive participants. RESULTS: We recruited 719 participants, of whom 119 (16.6%) were seeds. Our estimate of the population prevalence of HIV was 23.4% [95% confidence interval (CI): 15.8% to 31.0%] after RDS adjustments. We estimated that 18.6% (95% CI: 8.8% to 30.4%) of HIV-positive MSM in Vancouver had a VL of ≥200 copies per milliliter. Having an unsuppressed VL was associated with non-white ethnicity [adjusted odds ratio (AOR) = 4.34; 95% CI: 1.67 to 11.1], an annual income of <$15,000 CAD (AOR = 6.43; 95% CI: 2.08 to 19.9), using gamma-hydroxy butyrate in the previous 6 months (AOR = 4.85; 95% CI: 1.79 to 13.2), unprotected anal intercourse with a known HIV-negative or an unknown serostatus partner (AOR = 3.13; 95% CI: 1.10 to 8.90), and disclosing one's HIV serostatus ≥50% of the time (AOR = 7.04; 95% CI: 1.01 to 49.1). CONCLUSION: Despite a high prevalence of HIV, we estimated that a small proportion of HIV-positive MSM have undiagnosed HIV and unsuppressed VL. Our results highlight the importance of continued work to address health inequities using a framework based on social determinants of health.
BACKGROUND: We developed estimates of community viral load (VL) and risk factors for unsuppressed VL from a cross-sectional study of men who have sex with men (MSM) in Vancouver, Canada. METHODS: MSM were recruited from February 25, 2012 to February 28, 2014 using respondent-driven sampling (RDS). Participants completed a computer-assisted self-interview questionnaire and a nurse-administered point-of-care HIV test. For HIV-positive participants, we conducted VL and CD4 cell counts. We used RDS-weighted analysis to obtain population estimates of key variables and multivariable logistic regression to examine factors associated with having a VL of ≥200 copies per milliliter among HIV-positive participants. RESULTS: We recruited 719 participants, of whom 119 (16.6%) were seeds. Our estimate of the population prevalence of HIV was 23.4% [95% confidence interval (CI): 15.8% to 31.0%] after RDS adjustments. We estimated that 18.6% (95% CI: 8.8% to 30.4%) of HIV-positive MSM in Vancouver had a VL of ≥200 copies per milliliter. Having an unsuppressed VL was associated with non-white ethnicity [adjusted odds ratio (AOR) = 4.34; 95% CI: 1.67 to 11.1], an annual income of <$15,000 CAD (AOR = 6.43; 95% CI: 2.08 to 19.9), using gamma-hydroxy butyrate in the previous 6 months (AOR = 4.85; 95% CI: 1.79 to 13.2), unprotected anal intercourse with a known HIV-negative or an unknown serostatus partner (AOR = 3.13; 95% CI: 1.10 to 8.90), and disclosing one's HIV serostatus ≥50% of the time (AOR = 7.04; 95% CI: 1.01 to 49.1). CONCLUSION: Despite a high prevalence of HIV, we estimated that a small proportion of HIV-positive MSM have undiagnosed HIV and unsuppressed VL. Our results highlight the importance of continued work to address health inequities using a framework based on social determinants of health.
Authors: Hilary H Spindler; Susan Scheer; Sanny Y Chen; Jeffrey D Klausner; Mitchell H Katz; Linda A Valleroy; Sandra K Schwarcz Journal: Sex Transm Dis Date: 2007-08 Impact factor: 2.830
Authors: Hyman M Scott; Eric Vittinghoff; Risha Irvin; Darpun Sachdev; Albert Liu; Marc Gurwith; Susan P Buchbinder Journal: J Acquir Immune Defic Syndr Date: 2014-01-01 Impact factor: 3.731
Authors: Fabienne Laraque; Heather A Mavronicolas; McKaylee M Robertson; Heidi W Gortakowski; Arpi S Terzian Journal: AIDS Date: 2013-08-24 Impact factor: 4.177
Authors: Marina Daskalopoulou; Alison Rodger; Andrew N Phillips; Lorraine Sherr; Andrew Speakman; Simon Collins; Jonathan Elford; Margaret A Johnson; Richard Gilson; Martin Fisher; Ed Wilkins; Jane Anderson; Jeffrey McDonnell; Simon Edwards; Nicky Perry; Rebecca O'Connell; Monica Lascar; Martin Jones; Anne M Johnson; Graham Hart; Alec Miners; Anna-Maria Geretti; William J Burman; Fiona C Lampe Journal: Lancet HIV Date: 2014-09-07 Impact factor: 12.767
Authors: Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall Journal: Lancet Date: 2010-07-16 Impact factor: 79.321
Authors: Moupali Das; Priscilla Lee Chu; Glenn-Milo Santos; Susan Scheer; Eric Vittinghoff; Willi McFarland; Grant N Colfax Journal: PLoS One Date: 2010-06-10 Impact factor: 3.240
Authors: Jamie I Forrest; Benjamin Stevenson; Ashleigh Rich; Warren Michelow; Jayaram Pai; Jody Jollimore; H Fisher Raymond; David Moore; Robert S Hogg; Eric A Roth Journal: Cult Health Sex Date: 2014-02-10
Authors: Christine L Mattson; Mark Freedman; Jennifer L Fagan; Emma L Frazier; Linda Beer; Ping Huang; Eduardo E Valverde; Christopher Johnson; Catherine Sanders; A D McNaghten; Patrick Sullivan; Amy Lansky; Jonathan Mermin; James Heffelfinger; Jacek Skarbinski Journal: AIDS Date: 2014-05-15 Impact factor: 4.177
Authors: Ashleigh J Rich; Nathan J Lachowsky; Paul Sereda; Zishan Cui; Jason Wong; Stanley Wong; Jody Jollimore; Henry Fisher Raymond; Travis Salway Hottes; Eric A Roth; Robert S Hogg; David M Moore Journal: J Urban Health Date: 2018-04 Impact factor: 3.671
Authors: Kiffer G Card; Heather L Armstrong; Allison Carter; Zishan Cui; Lu Wang; Julia Zhu; Nathan J Lachowsky; David M Moore; Robert S Hogg; Eric A Roth Journal: Drug Alcohol Depend Date: 2018-05-22 Impact factor: 4.492
Authors: Kiffer G Card; Nathan J Lachowsky; Zishan Cui; Susan Shurgold; Heather L Armstrong; Ashleigh J Rich; Jamie I Forrest; Maya Gislason; David M Moore; Eric A Roth; Robert S Hogg Journal: AIDS Educ Prev Date: 2017-04
Authors: Helia Shariati; Heather L Armstrong; Zishan Cui; Nathan J Lachowsky; Julia Zhu; Praney Anand; Eric A Roth; Robert S Hogg; Greg Oudman; Christina Tonella; David M Moore Journal: Drug Alcohol Depend Date: 2017-08-16 Impact factor: 4.492
Authors: K Closson; N J Lachowsky; Z Cui; S Shurgold; P Sereda; A Rich; D M Moore; E A Roth; R S Hogg Journal: Sex Transm Infect Date: 2016-11-16 Impact factor: 3.519
Authors: Brooke Cheng; Jordan M Sang; Zishan Cui; Nicanor Bacani; Heather L Armstrong; Julia Zhu; Julius Elefante; Gbolahan Olarewaju; Kiffer G Card; Everett Blackwell; Nathan J Lachowsky; Robert S Hogg; Eric A Roth; David M Moore Journal: Subst Use Misuse Date: 2020-05-14 Impact factor: 2.164
Authors: Benjamin J Klassen; Nathan J Lachowsky; Sally Yue Lin; Joshua B Edward; Sarah A Chown; Robert S Hogg; David M Moore; Eric A Roth Journal: Qual Health Res Date: 2017-07-01
Authors: Nathan John Lachowsky; Zach Tanner; Zishan Cui; Paul Sereda; Asheligh Rich; Jody Jollimore; Julio Sg Montaner; Robert S Hogg; David M Moore; Eric A Roth Journal: Sex Transm Dis Date: 2016-12 Impact factor: 2.830
Authors: Heather L Armstrong; Eric Abella Roth; Ashleigh Rich; Nathan J Lachowsky; Zishan Cui; Paul Sereda; Kiffer G Card; Jody Jollimore; Terry Howard; David M Moore; Robert S Hogg Journal: AIDS Care Date: 2018-03-20
Authors: Kiffer G Card; Nathan J Lachowsky; Zishan Cui; Paul Sereda; Ashleigh Rich; Jody Jollimore; Terry Howard; Robert Birch; Allison Carter; Julio Montaner; David Moore; Robert S Hogg; Eric Abella Roth Journal: AIDS Behav Date: 2017-05